DTRF funds innovative research on desmoid tumors, prioritizing projects that explore disease biology, novel therapies, and translational approaches to improve understanding and treatment.
Supports early career scientists advancing innovative research on the biology, diagnosis, and treatment of desmoid tumors through basic, translational, clinical, or computational approaches.
Grant Requests support investigators pursuing new leiomyosarcoma research to improve understanding of the disease, develop diagnostic tools and prognostic markers, and advance treatments.
Drug Discovery Initiative (DDI) supports researchers testing novel or repurposed NF therapies and validating therapeutic targets to generate preliminary data and advance drug discovery.
Discovery Grants from the American Brain Tumor Association support early-stage faculty testing high-risk brain tumor research ideas to generate preliminary data and potentially change diagnosis or treatment.
Accelerator Awards support investigators pursuing ambitious four-year neuroendocrine cancer research to advance early detection, develop new therapies, and match treatments to individual tumor biology.